moxalactam has been researched along with sch 29482 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fekety, FR; McClatchey, KD; Pierson, CL; Schaberg, DR | 1 |
| Adamsson, L; Dornbusch, K; Gezelius, L; Hallander, H | 1 |
2 other study(ies) available for moxalactam and sch 29482
| Article | Year |
|---|---|
In-vitro activity of Sch 29482, MK 0787, ceftriaxone and seven other antimicrobials against 840 separate clinical isolates.
Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefotaxime; Ceftriaxone; Cephamycins; Humans; Imipenem; Lactams; Methicillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance | 1982 |
In-vitro activity and beta-lactamase stability of Sch 29482, a penem antibiotic. Comparisons with ceftazidime and moxalactam.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Ceftazidime; Cephalosporins; Cephamycins; Culture Media; Drug Stability; Lactams; Microbial Sensitivity Tests; Moxalactam | 1982 |